Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP260845.RA5uoBtWRW-A30iJ6lzieSGU-Vua0rJZA4MsUaFBAuVu8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP260845.RA5uoBtWRW-A30iJ6lzieSGU-Vua0rJZA4MsUaFBAuVu8130_assertion type Assertion NP260845.RA5uoBtWRW-A30iJ6lzieSGU-Vua0rJZA4MsUaFBAuVu8130_head.
- NP260845.RA5uoBtWRW-A30iJ6lzieSGU-Vua0rJZA4MsUaFBAuVu8130_assertion wasGeneratedBy ECO_0000203 NP260845.RA5uoBtWRW-A30iJ6lzieSGU-Vua0rJZA4MsUaFBAuVu8130_provenance.
- NP260845.RA5uoBtWRW-A30iJ6lzieSGU-Vua0rJZA4MsUaFBAuVu8130_assertion wasDerivedFrom befree-20150227 NP260845.RA5uoBtWRW-A30iJ6lzieSGU-Vua0rJZA4MsUaFBAuVu8130_provenance.
- NP260845.RA5uoBtWRW-A30iJ6lzieSGU-Vua0rJZA4MsUaFBAuVu8130_assertion SIO_000772 11986399 NP260845.RA5uoBtWRW-A30iJ6lzieSGU-Vua0rJZA4MsUaFBAuVu8130_provenance.
- NP260845.RA5uoBtWRW-A30iJ6lzieSGU-Vua0rJZA4MsUaFBAuVu8130_assertion evidence source_evidence_literature NP260845.RA5uoBtWRW-A30iJ6lzieSGU-Vua0rJZA4MsUaFBAuVu8130_provenance.
- NP260845.RA5uoBtWRW-A30iJ6lzieSGU-Vua0rJZA4MsUaFBAuVu8130_assertion description "[We examined 14 cell lines, 11 reactive lymphoid tissues, and 57 primary hematopoietic neoplasms including mantle cell lymphoma (MCL) (n = 10), chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) (n = 11), acute lymphoblastic leukemia/lymphoma (n = 15), follicular lymphoma (n = 6), peripheral T-cell lymphoma (PTCL) (n = 3), anaplastic large cell lymphoma (n = 3), hairy cell leukemia (n = 3), Burkitt lymphoma (n = 1), Burkitt-like lymphoma (n = 4), and plasmacytoma (n = 1) for the expression of cyclin D1 mRNA using fluorescently labeled sequence-specific hybridization probes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP260845.RA5uoBtWRW-A30iJ6lzieSGU-Vua0rJZA4MsUaFBAuVu8130_provenance.